SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-15-235205
Filing Date
2015-06-25
Accepted
2015-06-25 16:44:29
Documents
1
Group Members
CL ALASKA, L.P.CRESTLINE INVESTORS, INC. (''CRESTLINE'')CRESTLINE MANAGEMENT, L.P. (''CRESTLINE MANAGEMENT'')CRESTLINE SI (GP), L.P. (''CRESTLINE SI'')

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 d949279dsc13da.htm SC 13D/A 102210
  Complete submission text file 0001193125-15-235205.txt   103702
Mailing Address 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102
Business Address
BRATTON DOUGLAS K (Filed by) CIK: 0001281933 (see all company filings)

Type: SC 13D/A

Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2066960703
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88476 | Film No.: 15952242
SIC: 2836 Biological Products, (No Diagnostic Substances)